Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. Ravina B, et al. Among authors: eberly s. Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690. Mov Disord. 2009. PMID: 19691116
A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.
Hayete B, Wuest D, Laramie J, McDonagh P, Church B, Eberly S, Lang A, Marek K, Runge K, Shoulson I, Singleton A, Tanner C, Khalil I, Verma A, Ravina B. Hayete B, et al. Among authors: eberly s. PLoS One. 2017 Jun 12;12(6):e0178982. doi: 10.1371/journal.pone.0178982. eCollection 2017. PLoS One. 2017. PMID: 28604798 Free PMC article.
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease.
Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I; PSG PostCEPT (LABS‐PD) Investigators. Kurlan R, et al. Among authors: eberly s. Mov Disord Clin Pract. 2015 Dec 14;3(1):53-58. doi: 10.1002/mdc3.12273. eCollection 2016 Jan-Feb. Mov Disord Clin Pract. 2015. PMID: 30363507 Free PMC article.
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.
Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I. Ravina B, et al. Among authors: eberly s. Mov Disord. 2012 Sep 15;27(11):1392-7. doi: 10.1002/mds.25157. Epub 2012 Sep 13. Mov Disord. 2012. PMID: 22976926 Free PMC article.
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
Mills KA, Schneider RB, Saint-Hilaire M, Ross GW, Hauser RA, Lang AE, Halverson MJ, Oakes D, Eberly S, Litvan I, Blindauer K, Aquino C, Simuni T, Marras C. Mills KA, et al. Among authors: eberly s. Parkinsonism Relat Disord. 2020 Nov;80:127-132. doi: 10.1016/j.parkreldis.2020.09.028. Epub 2020 Sep 20. Parkinsonism Relat Disord. 2020. PMID: 32987359 Clinical Trial.
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Iwaki H, Blauwendraat C, Leonard HL, Makarious MB, Kim JJ, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Smolensky L, Amondikar N, Hutten SJ, Frasier M, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Gibbs RJ, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Andreassen OA, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA. Iwaki H, et al. Among authors: eberly s. Mov Disord. 2021 Jan;36(1):106-117. doi: 10.1002/mds.28312. Epub 2020 Oct 1. Mov Disord. 2021. PMID: 33002231 Free PMC article.
157 results